Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy

OBJECTIVE: Rifaximin is used to treat hepatic encephalopathy. However, whether or not rifaximin and lactulose combination therapy can enhance the treatment outcomes and reduce the hospitalization rate of patients with hepatic encephalopathy that are resistant to lactulose has yet to be determined. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayakawa, Yuka, Tamaki, Nobuharu, Nakanishi, Hiroyuki, Kurosaki, Masayuki, Tanaka, Yuki, Inada, Kento, Ishido, Shun, Kirino, Sakura, Yamashita, Koji, Nobusawa, Tsubasa, Matsumoto, Hiroaki, Kakegawa, Tatsuya, Higuchi, Mayu, Takaura, Kenta, Tanaka, Shohei, Maeyashiki, Chiaki, Kaneko, Shun, Yasui, Yutaka, Takahashi, Yuka, Tsuchiya, Kaoru, Okamoto, Ryuichi, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125807/
https://www.ncbi.nlm.nih.gov/pubmed/36070941
http://dx.doi.org/10.2169/internalmedicine.0212-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125807/
https://www.ncbi.nlm.nih.gov/pubmed/36070941
http://dx.doi.org/10.2169/internalmedicine.0212-22

Ejemplares similares